VNRX: VolitionRx Limited Stock

by  •  • Comments Off on VNRX: VolitionRx Limited Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 49.24
Enterprise Value ($M) 32.43
Book Value ($M) -8.71
Book Value / Share -0.11
Price / Book -5.65
NCAV ($M) -14.81
NCAV / Share -0.18
Price / NCAV -3.33

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.96
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.69
Current Ratio 0.69

Balance Sheet (mrq) ($M)
Current Assets 21.85
Assets 27.95
Liabilities 36.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.78
Operating Income -35.99
Net Income -35.32
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.06
Cash from Investing -1.08
Cash from Financing 28.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Lagoda Investment Management, L.P. 4.70 -0.70
02-09 13D/A Reynolds Cameron John 3.50 7.27

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 894,613 3,286,980 27.22
2024-04-22 16,009 51,117 31.32
2024-04-19 52,328 245,813 21.29
2024-04-18 27,782 255,788 10.86

(click for more detail)

Similar Companies
SCPX – Scorpius Holdings, Inc. TOVX – Theriva Biologics, Inc.
VCXB – 10X Capital Venture Acquisition Corp. III XTNT – Xtant Medical Holdings, Inc.


Financial data and stock pages provided by
Fintel.io